The store will not work correctly when cookies are disabled.
1-(3-Methylbenzoyl)-6-nitro-1H-indazole-3-carboxylic Acid methyl ester
ID: ALA2409445
PubChem CID: 71818404
Max Phase: Preclinical
Molecular Formula: C17H13N3O5
Molecular Weight: 339.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)c1nn(C(=O)c2cccc(C)c2)c2cc([N+](=O)[O-])ccc12
Standard InChI: InChI=1S/C17H13N3O5/c1-10-4-3-5-11(8-10)16(21)19-14-9-12(20(23)24)6-7-13(14)15(18-19)17(22)25-2/h3-9H,1-2H3
Standard InChI Key: ZOKSKHWGOAWJSA-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
2.3552 -9.5958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3541 -10.4153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0621 -10.8243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0603 -9.1869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7690 -9.5922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7692 -10.4153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5505 -10.6722 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0359 -10.0034 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5514 -9.3382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5368 -11.4878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8218 -11.8835 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2370 -11.9093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2198 -12.7251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9191 -13.1464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6351 -12.7508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6475 -11.9294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9476 -11.5118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9257 -8.6117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7420 -8.5727 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1840 -9.2601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4838 -7.9244 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3612 -11.5313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6441 -10.8226 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6435 -11.6398 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.9367 -10.4134 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 2 0
10 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
9 18 1 0
18 19 1 0
19 20 1 0
18 21 2 0
16 22 1 0
23 24 2 0
23 25 1 0
2 23 1 0
M CHG 2 23 1 25 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 339.31 | Molecular Weight (Monoisotopic): 339.0855 | AlogP: 2.73 | #Rotatable Bonds: 3 |
Polar Surface Area: 104.33 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.11 | CX LogD: 3.11 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.41 | Np Likeness Score: -1.54 |
References
1. Crocetti L, Schepetkin IA, Cilibrizzi A, Graziano A, Vergelli C, Giomi D, Khlebnikov AI, Quinn MT, Giovannoni MP.. (2013) Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase., 56 (15): [PMID:23844670] [10.1021/jm400742j] |